Aurora Cannabis and Radient Technologies Sign Master Services Agreement
Companies Also Sign Investor Rights Agreement
VANCOUVER, Nov. 6, 2017 /CNW/ – Further to the two companies’ joint press release of October 23, 2017, Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSX: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM)) and Radient Technologies Inc. (“Radient”) (TSXV: RTI) today announced the companies have finalized a Master Services Agreement (the “Agreement”), pursuant to which Radient has agreed to perform certain services for Aurora using its proprietary MAP™ technology, as well as other technologies, as an independent contractor in relation to the development, commercialization and supply of standardized cannabis extracts. The Agreement has an initial term of five years, with an option for Aurora to renew the agreement for an additional five years.
Under the terms of the agreement, Radient will provide processing services to Aurora for the production of extracts from material supplied by the Company, which may include both cannabis and hemp. The agreement initially covers services delivered in Canada, Australia, and the European Union, including Germany where Aurora’s wholly owned subsidiary Pedanios is the largest distributor of medical cannabis on the continent. Additionally, Aurora has the right to negotiate on an exclusive basis with Radient to expand the jurisdictions covered. Within the countries covered by the agreement, Radient shall deliver its services under preferential terms to Aurora.
Radient applied in December, 2016 to Health Canada to obtain Licensed Dealer status, and in February, 2017 for Licensed Producer status, and is progressing well through the processes. Upon receipt of either license, Radient will be able to commence production of cannabis extracts from products supplied by Aurora or Aurora’s partners.
This agreement will enable us, in the very near future, to dramatically accelerate the production of high-margin cannabis derivatives under favourable terms. The market for non-smoked derivative cannabis products is growing at a remarkable pace, and through this agreement we have a cost-effective and scalable means to help meet this demand – particularly once we begin harvests in the first half of 2018 at our 100,000+ kg per annum Aurora Sky production facility. We intend to continue our collaboration with Radient on other R&D projects that we expect will deliver significant value to both companies.
Terry Booth, CEO
Denis Taschuk, CEO of Radient, added, “This agreement brings together the industry’s most technologically advanced cultivation facility, Aurora Sky, with the industry’s most advanced extraction platform, Radient’s MAP™. With a shared commitment to world-leading quality assurance and the development of innovative products, we are excited about the benefits this partnership will bring to our respective stakeholders.”
The Master Services Agreement includes an Investor Rights Agreement that provides Aurora with certain rights to participate in future offerings, providing Aurora with the option to expand its ownership in Radient up to 19.99%. Aurora also has the right to appoint one director to the Radient Board of Directors.
Aurora’s wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”). The Company operates a 55,200 square foot, state-of-the-art production facility in Mountain View County, Alberta, known as “Aurora Mountain”, a second 40,000 square foot high-technology production facility known as “Aurora Vie” in Pointe-Claire, Quebec on Montreal’s West Island, and is currently constructing an 800,000 square foot production facility, known as “Aurora Sky”, at the Edmonton International Airport.
In addition, the Company holds approximately 9.6% of the issued shares (12.9% on a fully-diluted basis) in leading extraction technology company Radient Technologies Inc., based in Edmonton, and is in the process of completing an investment in Edmonton-based Hempco Food and Fiber for an ownership stake of up to 50.1%. Furthermore, Aurora is the cornerstone investor with a 19.9% stake in Cann Group Limited, the first Australian company licensed to conduct research on and cultivate medical cannabis. Aurora also owns Pedanios, a leading wholesale importer, exporter, and distributor of medical cannabis in the European Union, based in Germany. The Company offers further differentiation through its acquisition of BC Northern Lights Ltd. and Urban Cultivator Inc., industry leaders, respectively, in the production and sale of proprietary systems for the safe, efficient and high-yield indoor cultivation of cannabis, and in state-of-the-art indoor gardening appliances for the cultivation of organic microgreens, vegetables and herbs in home and professional kitchens. Aurora’s common shares trade on the TSX under the symbol “ACB”.
Radient extracts natural compounds from a range of biological materials using its proprietary MAPTM natural product extraction technology platform which provides superior customer outcomes in terms of ingredient purity, yield, and cost. From its initial 20,000 square foot manufacturing plant in Edmonton, Alberta, Radient serves market leaders in industries that include pharmaceutical, food, beverage, natural health, personal care and biofuel markets. Visit www.radientinc.com for more information.
Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.